Thrombospondin (TSP), an adhesive integrin-binding protein of plasma and platelets, was detected in preretinal traction membranes from patients with idiopathic (8/8) and traumatic (7/8) proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR) (6/8). TSP immunoreactivity was compared to the pattern of von Willebrand factor, plasma transglutaminase (blood coagulation factor XIII), fibronectin, and mononuclear phagocytes, using double-label immunoflurorescence microscopy. TSP was partially colocalised with the endothelial cell marker, von Willebrand factor, in PDR. The codistribution of catalytic factor XIII and two cross-linking substrates, fibronectin and TSP, suggests a functional role of the enzyme in the extracellular matrix build-up in PVR and PDR. No significant TSP synthesis by mononuclear phagocytes was observed. Western blotting indicated a plasmin-mediated intravitreal breakdown of presumably plasmatic TSP in PVR and PDR.
CanfieldA.E., SchorA.M., LoskutoffD.J., SchorS.L., GrantM.E.Plasminogen activator inhibitior-type I is a major biosynthetic product of retinal microvascular endothelial cells and pericytes in culture. Biochem J1989; 259: 529–35.
TuszynskiG.P., KarczewskiJ., SmithL., MurphyA., RothmanV.L., KnudsenK.A.The GPIIB-IIIa-IIike complex may function as a human melanoma cell adhesion receptor for thrombospondin. Exp Cell Res1989; 182: 473–81.
7.
LawlerJ., WeinsteinR., HynesR.O.Cell attachment to thrombospondin; the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol1988; 107: 2351–61.
HiscottP.S., GriersonI., Mc LeodD.Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol1985; 69: 810–23.
WellerM., WiedemannP., HeimannK., ZillesK.The significance of fibronectin in vitreoretinal pathology: a critical evaluation. Graefe's Arch Clin Exp Ophthalmol1988; 226: 294–8.
12.
WellerM., BresgenM., HeimannK., WiedemannP.Vitronectin and proliferative vitreoretinal disorders. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy. Int Ophthalmol1991; 15: 93–101.
PhanS.H., DillonR.G., McGarryB.M., DixitV.M.Stimulation of fibroblast proliferation by thrombospondin. Biochem Biophys Res Commun1989; 163: 56–63.
15.
WellerM., HeimannK., WiedemannP.Immunochemical analysis of periretinal membranes. Review and outlook. Dev Ophthalmol1989; 16: 54–74.
16.
WellerM., HeimannK., WiedemannP.Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy. Int Ophthalmol1988; 11: 181–6.
17.
WellerM., BresgenM., HeimannK., WiedemannP.Blood coagulation factor XIII contributes to the development of traction retinal detachment. Acta Ophthalmol1990; 68: 246–52.
TowbinH., GordonJ.Immunoblotting and dot immunobinding - current status and outlook. J Immunol Methods1984; 72: 313–40.
20.
DreyfusM., LahavJ.The build-up of the thrombospondin extracellular matrix. An apparent dependence on synthesis and on preformed fibrillar matrix. Eur J Cell Biol1988; 47: 275–82.
21.
LynchG.W., SlayterH.S., MillerB.E., McDonaghJ.Characterization of thrombospondin as a substrate for factor XIII transglutaminase. J Biol Chem1987; 262: 1772–8.
22.
McGregorJ.L., CatimelB., ParmentierS., ClezardinP., DechavanneM., LeungL.L.Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem1989; 264: 501–6.
23.
SilversteinR.L., AschA.S., NachmanR.L.Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest1989; 84: 546–52.
24.
LiauG., ChanL.M.Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. J Biol Chem1989; 264: 10315–20.
25.
ConnorT.B.Jr., RobertsA.B., SpornM.B.Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest1989; 83: 1661–6.
26.
MarderV.J., MannucciP.M., FirkinB.G., HoyerL.W., MeyerD.Standard nomenclature for factor VIII and von Willebrand factor: A recommendation by the International Committee on Thrombosis and Haemostasis. Thromb Haemost1985; 54: 871–2.
27.
RaugiG.J., OlerudJ.E., GownA.M.Thrombospondin in early human wound tissue. J Invest Dermatol1987; 89: 551–4.
28.
DavesJ., PrattD.A., DewarM.S., PrestonF.E.Do extraplatelet sources contribute to the plasma level of thrombospondin?Thromb Haemost1988; 59: 273–6.
YabrowitzR., LoweJ.B., DixitV.M.Expression and initial characterization of a recombinant human thrombospondin heparin binding domain. J Biol Chem1989; 264: 10888–96.
31.
JohnsonR.N., BlankenshipG.A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin. Ophthalmology1988; 95: 312–7.
